Position in PSNL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$13,909,353
+$276,644 QoQ
Shares Held
2,183,572
+27.5% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $48,575,766 across 13 Diagnostics & Research names. PSNL ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
This page
|
2,183,572 | $13,909,353 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,634 | $7,526,865 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
14,073 | $6,917,301 | |
| 4 | A |
Agilent Technologies, Inc.
|
41,202 | $4,696,203 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
931,522 | $3,232,381 | |
| 6 | DHR |
Danaher Corp /De/
|
14,638 | $2,775,364 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
34,562 | $2,219,571 | |
| 8 | VCYT |
Veracyte, Inc.
|
54,320 | $1,749,647 |
All Filings in PSNL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,909,353 | 2,183,572 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,632,709 | 1,712,652 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,616,708 | 1,935,078 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,286,192 | 653,383 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,121,057 | 604,290 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||